References

Batki, S.L.  Treatment of intravenous drug users with AIDS: 
The role of methadone maintenance. 
Journal
of Psychoactive Drugs
1988 20: 213-216.



Legal Action Center. Beazer vs New York City Transit
Authority: A Landmark Decision on Methadone Maintenance

[Report].  New York:
National Institute on Drug Abuse, 1975.

 

Des
Jarlais, D.C.; Friedman, S.R.; Novick, D.M. et al.  HIV-1 infection among intravenous drug users in Manhattan. 
Journal
of the American Medical Association
1989 261: 1008-1012.

 

Dole,
V.P.; Nyswander, M.E. Heroin addiction: Metabolic disease. Archives of Internal Medicine
1967 120: 19-24.

 

Dole,
V.P.; Nyswander, M.E.  A
medical treatment for diacetylmorphine (heroin) addiction.  Journal of the American Medical Association 1965 (August 23)
193(8): 646-650.

 

Dole,
V.P.; Nyswander, M.E.; Kreek, M.J. 
Narcotic blockade.  Archives
of Internal Medicine
1966 
(October) 118:304-309.

 

Goldstein,
D.  Personal communication,
Eli Lilly Pharmaceuticals, 1992.

 

Joseph,
H; Springer, E.  Methadone
maintenance treatment and the AIDS epidemic. 
In:  The Effectiveness of Drug Abuse
Treatment: Dutch and American Perspectives
. p 261-274. 
Malabar, Florida: Robert E. Krieger, 1990.

 

Kreek,
M.J.  Health consequences
associated with the use of methadone. 
In:  Cooper, J.R.;
Altman, F.; Brown, B.S.; Czechowicz, D. (eds), Research
on the Treatment of Narcotic Addiction: 
State of the Art
(NIDA Research Monograph 83-1201). 
Rockville, MD: National Institute on Drug Abuse, 1983.

 

Platt,
J.J.  Heroin Addiction: 
Theory, Research and Treatment
. 
Malabar, FL:  Kreiger, 1988. 

 

Sells,
S.B.  Effectiveness of Drug Abuse Treatment:
Volume 1 Evaluation of Treatments
. 
Cambridge:  Ballinger,
1974a.

 

 

Sells,
S.B.  Effectiveness of Drug Abuse Treatment:
Volume 2 Research on Patients, Treatments, and Outcomes
. 
Cambridge:  Ballinger,
1974b.

 

Sells,
S.B; Simpson, D.D. The case for drug abuse treatment effectiveness,
based on the DARP research program. British
Journal of Addiction
1980 75: 117-131.

 

Sells, S.B; Simpson, D.D. Effectiveness
of Drug Abuse Treatment: Volume 3 Further Studies of Drug Users,
Treatment Typologies and Assessment of Outcome During Treatment in the
DARP
.  Cambridge: 
Ballinger, 1976a.

 

Sells, S.B.; Simpson, D.D. 
Effectiveness
of Drug Abuse Treatment: Volume 4 Evaluation of Treatment Outcomes for
the 1971-1972 Admission Cohort
. 
Cambridge:  Ballinger,
1976b.

 

Sells, S.B.; Simpson, D.D. 
Effectiveness
of Drug Abuse Treatment: Volume 5 Evaluation of Treatment Outcomes for
the 1972-1973 Admission Cohort
. 
Cambridge:  Ballinger,
1976c.



Goldstein,
D.  Personal communication,
Eli Lilly Pharmaceuticals, 1992.

 

Joseph,
H; Springer, E.  Methadone
maintenance treatment and the AIDS epidemic. 
In:  The Effectiveness of Drug Abuse
Treatment: Dutch and American Perspectives
. p 261-274. 
Malabar, Florida: Robert E. Krieger, 1990.

 

Kreek,
M.J.  Health consequences
associated with the use of methadone. 
In:  Cooper, J.R.;
Altman, F.; Brown, B.S.; Czechowicz, D. (eds), Research
on the Treatment of Narcotic Addiction: 
State of the Art
(NIDA Research Monograph 83-1201). 
Rockville, MD: National Institute on Drug Abuse, 1983.

 

Platt,
J.J.  Heroin Addiction: 
Theory, Research and Treatment
. 
Malabar, FL:  Kreiger, 1988. 

 

Sells,
S.B.  Effectiveness of Drug Abuse Treatment:
Volume 1 Evaluation of Treatments
. 
Cambridge:  Ballinger,
1974a.

Similar Posts

  • Expectations

    Admin 09/04/2021

    Every patient, in fact every member of the methadone community, has a right to expect that someone who represents themselves as a methadone advocate be knowledgeable in all aspects of methadone treatment. NAMA has created the Methadone Advocate Training and Methadone Advocate Certification for a whole host of reasons. Most of which we will discuss…

  • |

    Stigma: The Invisible Barrier by Herman Joseph, Ph.D. and Joycelyn Woods, M.A.

    Admin 03/28/2021

    Herman Joseph, Ph.D. is a member of NAMA’s Advisory Board and has been involved in methadone treatment and research since it’s beginning. This article is excerpted from Dr. Joseph’s dissertation on stigma. Joycelyn Woods, M.A. is Vice President of NAMA and has a graduate dreree in neuroscience and has worked in the field for twenty-five…

  • NAMA SITE SEARCH

    Admin 04/08/2022

    Search the NAMA site with Digital Equipment Corporation’s excellent ALTAVISTA search engine! Just type your search term(s) next to the text Reading “url:Methadone.org” Search for:    NOTE: This search takes you away from our site. Either use your browser’s “Back” button or choose one of the results returned by AltaVista to continue with us.  

  • The Advocacy Training Session

    Admin 12/18/2021

      The first training for certification will include a variety of topics to give advocates a well-grounded understanding of methadone treatment, research, regulations and laws that protect methadone patients and programs.   Addiction and Methadone– Tom Payte, MD (Drug Dependence Associates) and Joycelyn Woods, MA. (NAMA) The biological constructs of addiction will be explained in…

  • NAMA Affiliates Pages

    Admin 10/23/2022

    Affiliates Package The first 2 parts of the Affiliates Package are in Ebook format. This means that your computer sees the file as an application and it will have an “exe” file extension. If you click on the file like it is an application – the Ebook with the documents will open. You can then…

  • Accreditation, Advocacy and Patients in MAT

    Admin 10/31/2022

    James P. Connolly, CMA PA-NAMA and NAMA Newtown, PA Rebecca Ballard, CMA OK NAMA Tulsa, OK Carolyn Miranda, CMA NAMA SOCAL Fountain Valley, CA Changes in the service environment of MAT, expecially accreditation, are affecting relationships of patients, providers, and outside agencies. A panel of NAMA advocates will describe experiences with patient committees, staff advocacy…